Cargando…

Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea

PURPOSE: To assess the efficacy of photodynamic therapy (PDT) in patients with chronic central serous chorioretinopathy (cCSC), in whom subretinal fluid (SRF) was solely present outside the foveal area. METHODS: In this retrospective study, 16 eyes of 15 cCSC patients who received half-dose PDT beca...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Dijk, Elon H. C., Dijkman, Greet, Boon, Camiel J. F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Medical Ophthalmology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602371/ https://www.ncbi.nlm.nih.gov/pubmed/28674835 http://dx.doi.org/10.1007/s00417-017-3720-z

Ejemplares similares

Central serous chorioretinopathy in primary hyperaldosteronism
por: van Dijk, Elon H. C., et al.
Publicado: (2016)

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
por: van Rijssen, Thomas J., et al.
Publicado: (2018)

Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
por: van Rijssen, Thomas J., et al.
Publicado: (2020)

INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
por: Feenstra, Helena M. A., et al.
Publicado: (2023)

Subretinal fluid morphology in chronic central serous chorioretinopathy and its relationship to treatment: a retrospective analysis on PLACE trial data
por: Subhi, Yousif, et al.
Publicado: (2021)

Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy
por: Mohabati, Danial, et al.
Publicado: (2018)

Cushing’s Syndrome and Hypothalamic–Pituitary–Adrenal Axis Hyperactivity in Chronic Central Serous Chorioretinopathy
por: van Haalen, Femke M., et al.
Publicado: (2018)

Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy
por: van Rijssen, Thomas J., et al.
Publicado: (2018)

SINGLE-SESSION BILATERAL REDUCED-SETTINGS PHOTODYNAMIC THERAPY FOR BILATERAL CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
por: Pauleikhoff, Laurenz J.B., et al.
Publicado: (2023)

Long‐term follow‐up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser
por: van Rijssen, Thomas J., et al.
Publicado: (2021)

Interobserver Agreement of Novel Classification of Central Serous Chorioretinopathy
por: Sahoo, Niroj K, et al.
Publicado: (2022)

Sex Hormones in Males and Females with Active Central Serous Chorioretinopathy
por: Brinks, Joost, et al.
Publicado: (2023)

Bilateral Central Serous Chorioretinopathy After Treatment of COVID-19 Infection
por: Sharifi, Ali, et al.
Publicado: (2022)

Optical coherence tomography angiography of central serous chorioretinopathy: quantitative evaluation of the vascular pattern and capillary flow density
por: Roberta, Farci, et al.
Publicado: (2021)

Subretinal hyperreflective material in central serous chorioretinopathy
por: Sahoo, Niroj K, et al.
Publicado: (2020)

Systemic complement activation in central serous chorioretinopathy
por: van Dijk, Elon H. C., et al.
Publicado: (2017)

Photodynamic Therapy Rescue for Subretinal Fluid Exacerbation After Focal Laser Treatment in Idiopathic Central Serous Chorioretinopathy
por: Leng, Theodore, et al.
Publicado: (2011)

Stress and vision-related quality of life in acute and chronic central serous chorioretinopathy
por: Kumar, Meenakshi, et al.
Publicado: (2020)

The Uses of Photodynamic Therapy Versus Anti-vascular Endothelial Growth Factor in the Management of Acute Central Serous Chorioretinopathy: A Systematic Review and Meta-Analysis
por: Seraj, Hadeel, et al.
Publicado: (2023)

Exome sequencing in families with chronic central serous chorioretinopathy
por: Schellevis, Rosa L., et al.
Publicado: (2019)

Central serous chorioretinopathy in active endogenous Cushing’s syndrome
por: Brinks, Joost, et al.
Publicado: (2021)

Aflibercept as a Treatment for Secondary Central Serous Chorioretinopathy in a Patient With Myasthenia Gravis
por: Ramirez Marquez, Estefania, et al.
Publicado: (2022)

Retinal Imaging and Optical Coherence Tomography of Choroidal Haemangioma Mimicking Central Serous Chorioretinopathy
por: Jugnarain, Davina, et al.
Publicado: (2023)

Predicting subretinal fluid absorption with machine learning in patients with central serous chorioretinopathy
por: Xu, Fabao, et al.
Publicado: (2021)

Subretinal fluid disturbs the retinal venous blood flow in central serous chorioretinopathy
por: Lim, Joon Seo, et al.
Publicado: (2022)

Fundus autofluorescence abnormalities can predict fluorescein angiography abnormalities in patients with chronic central serous chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2023)

Prospective evaluation of changes in choroidal vascularity index after half-dose photodynamic therapy versus micropulse laser treatment in chronic central serous chorioretinopathy
por: van Rijssen, Thomas J., et al.
Publicado: (2020)

Evaluation of Choroidal Layer Thickness in Central Serous Chorioretinopathy
por: Hanumunthadu, Daren, et al.
Publicado: (2019)

Persistent subretinal fluid due to central serous chorioretinopathy after retinal detachment surgery
por: Moreno-López, María, et al.
Publicado: (2011)

Widefield choroidal vasculature associated with future condition of subretinal fluid in central serous chorioretinopathy
por: Kogo, Takahiro, et al.
Publicado: (2023)

Spectrum of retinal abnormalities in renal transplant patients using chronic low-dose steroids
por: van Dijk, Elon H. C., et al.
Publicado: (2017)

Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2018)

Photodynamic Therapy and Central Serous Chorioretinopathy
por: Siaudvytyte, Lina, et al.
Publicado: (2012)

Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities
por: Brinks, Joost, et al.
Publicado: (2022)

Bilateral and Multiple Central Serous Chorioretinopathy Following COVID-19 Infection: A Case Report and Literature Review
por: Mohd-Alif, W Mohd, et al.
Publicado: (2022)

Estimation of current and post-treatment retinal function in chronic central serous chorioretinopathy using artificial intelligence
por: Pfau, Maximilian, et al.
Publicado: (2021)

Short Term Presence of Subretinal Fluid in Central Serous Chorioretinopathy Affects Retinal Thickness and Function
por: Gawęcki, Maciej, et al.
Publicado: (2020)

Factors affecting resolution of subretinal fluid after selective retina therapy for central serous chorioretinopathy
por: Kyo, Akika, et al.
Publicado: (2021)

GENETIC RISK FACTORS IN SEVERE, NONSEVERE AND ACUTE PHENOTYPES OF CENTRAL SEROUS CHORIORETINOPATHY
por: Mohabati, Danial, et al.
Publicado: (2020)

Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d808d4umbpsm34hguv9m1blg5h